Article Details
Retrieved on: 2020-01-07 19:15:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Kohlberg Kravis Roberts</b> & Co. L.P. acquired a new position in BridgeBio Pharma in the 2nd quarter valued at $995,211,000. Viking Global Investors ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here